Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size

Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2011 by King Faisal Specialist Hospital & Research Center.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier:
NCT01310959
First received: March 6, 2011
Last updated: December 11, 2011
Last verified: December 2011
History of Changes
  Purpose
Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Condition Intervention
Aplastic Anemia and Other Marrow Failure Syndrome
 Other: Database

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by King Faisal Specialist Hospital & Research Center:
Estimated Enrollment: 88
Study Start Date: January 2003
Intervention Details:
    Other: Database
    Database
Detailed Description:
Establishing a Data Base for Aplastic Anemia and Other Marrow Failure Syndrome
  Eligibility
Ages Eligible for Study:   14 Years to 85 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Aplastic Anemia and Other Marrow Failure Syndrome Database
Criteria

Inclusion Criteria:

  • Patients with diagnosed Aplastic Anemia and Other Marrow Failure Syndrome Database.

Exclusion Criteria:

  • Patients with diagnosis other than Aplastic Anemia and Other Marrow Failure Syndrome Database.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01310959

Contacts
Contact: H Al-Zahrani, M.D. +966-1-4423949

Locations
Saudi Arabia
Kfsh & Rc Recruiting
Riyadh, Saudi Arabia
Sponsors and Collaborators
King Faisal Specialist Hospital & Research Center
Investigators
Principal Investigator: H Al-Zahrani, M.D. KFSH & RC
  More Information

Responsible Party: King Faisal Specialist Hospital & Research Center
ClinicalTrials.gov Identifier: NCT01310959     History of Changes
Other Study ID Numbers: RAC# 2021-084
Study First Received: March 6, 2011
Last Updated: December 11, 2011

Keywords provided by King Faisal Specialist Hospital & Research Center:
Aplastic Anemia Marrow Failure Syndrome

Additional relevant MeSH terms:
Syndrome
Anemia
Anemia, Aplastic
Disease
 Pathologic Processes
Hematologic Diseases
Bone Marrow Diseases

ClinicalTrials.gov processed this record on May 25, 2017